Assessment of estrogens in brain protection from traumatic brain injury. In collaboration with clinical scientists at the UT Southwestern Medical School, we are determining the effectiveness of estrogens from brain damage in traumatic brain injury.
Assessment of a computerized test for dementia in an ethnically diverse population. In collaboration with GreyMatter, Inc., we are assessing a touch-screen computerized test for cognitive status in the elderly.
The menopause and features of the hot flash. We are assessing the relationship between features of the hot flash and overall health of menopausal women.
The menopause and heart health. We are assessing the relationship between hot flashes during the menopause and the occurrence of hypertension and coronary artery disease.
Genetic variances and Alzheimer’s disease occurrence. We are assessing the role of genetic variances and the genes involved in Alzheimer’s disease.
The role of mitochondrial enhancers in lipid profiles in human subjects: We are assessing the effects in of interventions with mitochondrial enhancers on lipid profiles.
Effects of a mitochondrial electron rerouting agent on Parkinson’s disease. We are assessing the effects of methylene blue, a mitochondrial electron rerouting agent, on symptoms of Parkinson’s disease.
Novel estrogens and retinitis pigmentosa. We are assessing the effects of a novel estrogen in the protection of the eye form retinitis pigmentosa.